Processa Pharmaceuticals Inc (NASDAQ:PCSA)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PCSA

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PCSA

  • Market Cap$106.630m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS74275C2052

Company Profile

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100.Processa Pharmaceuticals Inc is a pharmaceutical company engaged in the development of drug products to improve the survival and/or quality of life for patients who have a high unmet medical need or who have no alternative treatment.

Latest PCSA news

Currently there for this company. Visit our news hub for other news .